129 related articles for article (PubMed ID: 38175982)
1. Retrospective Evaluation of Melphalan, Vincristine, and Cytarabine Chemotherapy for the Treatment of Relapsed Canine Lymphoma.
Duckett ME; Curran KM; Bracha S; Leeper HJ
J Am Anim Hosp Assoc; 2024 Jan; 60(1):7-14. PubMed ID: 38175982
[TBL] [Abstract][Full Text] [Related]
2. Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs.
Back AR; Schleis SE; Smrkovski OA; Lee J; Smith AN; Phillips JC
Vet Comp Oncol; 2015 Dec; 13(4):398-408. PubMed ID: 23910023
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and adverse event profile of dexamethasone, melphalan, actinomycin D, and cytosine arabinoside (DMAC) chemotherapy in relapsed canine lymphoma.
Parsons-Doherty M; Poirier VJ; Monteith G
Can Vet J; 2014 Feb; 55(2):175-80. PubMed ID: 24489398
[TBL] [Abstract][Full Text] [Related]
4. Combination of Bleomycin and Cytosine Arabinoside Chemotherapy for Relapsed Canine Lymphoma.
Batschinski K; Dervisis N; Kitchell B; Newman R; Erfourth T
J Am Anim Hosp Assoc; 2018; 54(3):150-155. PubMed ID: 29558212
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a multi-agent chemotherapy protocol combining dexamethasone, melphalan, actinomycin D, and cytarabine for the treatment of resistant canine non-Hodgkin high-grade lymphomas: a single centre's experience.
Smallwood K; Tanis JB; Grant IA; Blackwood L; Killick DR; Amores-Fuster I; Elliott J; Mas A; Harper A; Marrington M; Finotello R
Vet Comp Oncol; 2019 Jun; 17(2):165-173. PubMed ID: 30666777
[TBL] [Abstract][Full Text] [Related]
6. Oral melphalan for the treatment of relapsed canine lymphoma.
Mastromauro ML; Suter SE; Hauck ML; Hess PR
Vet Comp Oncol; 2018 Mar; 16(1):E123-E129. PubMed ID: 28941072
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone, melphalan, actinomycin D, cytosine arabinoside (DMAC) protocol for dogs with relapsed lymphoma.
Alvarez FJ; Kisseberth WC; Gallant SL; Couto CG
J Vet Intern Med; 2006; 20(5):1178-83. PubMed ID: 17063713
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009).
Fahey CE; Milner RJ; Barabas K; Lurie D; Kow K; Parfitt S; Lyles S; Clemente M
J Am Vet Med Assoc; 2011 Jul; 239(2):209-15. PubMed ID: 21756176
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and toxicity of carboplatin and cytarabine chemotherapy for dogs with relapsed or refractory lymphoma (2000-2013).
Gillem J; Giuffrida M; Krick E
Vet Comp Oncol; 2017 Jun; 15(2):400-410. PubMed ID: 26463827
[TBL] [Abstract][Full Text] [Related]
10. Comparison of COAP and UW-19 protocols for dogs with multicentric lymphoma.
Hosoya K; Kisseberth WC; Lord LK; Alvarez FJ; Lara-Garcia A; Kosarek CE; London CA; Couto CG
J Vet Intern Med; 2007; 21(6):1355-63. PubMed ID: 18196747
[TBL] [Abstract][Full Text] [Related]
11. Concurrent use of rabacfosadine and L-asparaginase for relapsed or refractory multicentric lymphoma in dogs.
Cawley JR; Wright ZM; Meleo K; Post GS; Clifford CA; Vickery KR; Vail DM; Bergman PJ; Thamm DH
J Vet Intern Med; 2020 Mar; 34(2):882-889. PubMed ID: 32064697
[TBL] [Abstract][Full Text] [Related]
12. Mechlorethamine, vincristine, melphalan and prednisolone rescue chemotherapy protocol for resistant feline lymphoma.
Martin OA; Price J
J Feline Med Surg; 2018 Oct; 20(10):934-939. PubMed ID: 29065803
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma.
Zimmerman K; Walsh KA; Ferrari JT; Keuler NS; Atherton MJ; Lenz JA
Vet Comp Oncol; 2023 Sep; 21(3):503-508. PubMed ID: 37222086
[TBL] [Abstract][Full Text] [Related]
14. A dexamethasone, melphalan, actinomycin-D and cytarabine chemotherapy protocol as a rescue treatment for feline lymphoma.
Elliott J; Finotello R
Vet Comp Oncol; 2018 Mar; 16(1):E144-E151. PubMed ID: 29044884
[TBL] [Abstract][Full Text] [Related]
15. Vinblastine as a second rescue for the treatment of canine multicentric lymphoma in 39 cases (2005 to 2014).
Lenz JA; Robat CS; Stein TJ
J Small Anim Pract; 2016 Aug; 57(8):429-34. PubMed ID: 27251593
[TBL] [Abstract][Full Text] [Related]
16. Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.
Arellano-Rodrigo E; López-Guillermo A; Bessell EM; Nomdedeu B; Montserrat E; Graus F
Eur J Haematol; 2003 Apr; 70(4):219-24. PubMed ID: 12656744
[TBL] [Abstract][Full Text] [Related]
17. Assessment of temporal association of relapse of canine multicentric lymphoma with components of the CHOP protocol: Is cyclophosphamide the weakest link?
Wang SL; Lee JJ; Liao AT
Vet J; 2016 Jul; 213():87-9. PubMed ID: 27240922
[TBL] [Abstract][Full Text] [Related]
18. High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study.
Josting A; Sieniawski M; Glossmann JP; Staak O; Nogova L; Peters N; Mapara M; Dörken B; Ko Y; Metzner B; Kisro J; Diehl V; Engert A
Ann Oncol; 2005 Aug; 16(8):1359-65. PubMed ID: 15939712
[TBL] [Abstract][Full Text] [Related]
19. Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma.
Smallwood K; Harper A; Blackwood L
J Feline Med Surg; 2021 Aug; 23(8):722-729. PubMed ID: 33176543
[TBL] [Abstract][Full Text] [Related]
20. Treatment of relapsed canine lymphoma with doxorubicin and dacarbazine.
Van Vechten M; Helfand SC; Jeglum KA
J Vet Intern Med; 1990; 4(4):187-91. PubMed ID: 2401965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]